Kevin T. Conroy - Jan 14, 2022 Form 4 Insider Report for EXACT SCIENCES CORP (EXAS)

Role
President and CEO, Director
Signature
/s/ Kevin T. Conroy by Mark R. Busch, attorney-in-fact
Stock symbol
EXAS
Transactions as of
Jan 14, 2022
Transactions value $
$0
Form type
4
Date filed
1/19/2022, 03:56 PM
Previous filing
Jan 4, 2022
Next filing
Jan 28, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXAS Common Stock Award $0 +6.41K +0.96% $0.00 671K Jan 14, 2022 Direct F1, F2, F3
holding EXAS Common Stock 26.6K Jan 14, 2022 Held in 401(k) Plan
holding EXAS Common Stock 21.7K Jan 14, 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Jan 14, 2022 Held in Grantor Retained Annuity Trust
holding EXAS Common Stock 21.7K Jan 14, 2022 Held in Grantor Retained Annuity Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units issued to Mr. Conroy in lieu of one-half of his base salary for 2022. The restricted stock units vest in eleven equal monthly installments beginning on February 15, 2022. Each restricted stock unit represents a right to receive one share of Common Stock.
F2 As these restricted stock units vest, Mr. Conroy expects to pay the relevant income taxes out of his base salary or cash on hand, rather than selling shares to cover them.
F3 In addition to the shares of Common Stock reported on this Form 4, which total 762,529 shares, Mr. Conroy also holds, in the aggregate, an additional 1,207,918 vested and unvested options to purchase shares of Common Stock and restricted stock units, with each restricted stock unit representing a contingent right to receive one share of Common Stock.